162 related articles for article (PubMed ID: 12678767)
21. Synthesis and biological evaluation of nonylprodigiosin and macrocyclic prodigiosin analogues.
Fürstner A; Grabowski J; Lehmann CW; Kataoka T; Nagai K
Chembiochem; 2001 Jan; 2(1):60-8. PubMed ID: 11828428
[TBL] [Abstract][Full Text] [Related]
22. Reversible and potent uncoupling of hog gastric (H(+)+K(+))-ATPase by prodigiosins.
Matsuya H; Okamoto M; Ochi T; Nishikawa A; Shimizu S; Kataoka T; Nagai K; Wasserman HH; Ohkuma S
Biochem Pharmacol; 2000 Dec; 60(12):1855-63. PubMed ID: 11108801
[TBL] [Abstract][Full Text] [Related]
23. Properties and applications of undecylprodigiosin and other bacterial prodigiosins.
Stankovic N; Senerovic L; Ilic-Tomic T; Vasiljevic B; Nikodinovic-Runic J
Appl Microbiol Biotechnol; 2014 May; 98(9):3841-58. PubMed ID: 24562326
[TBL] [Abstract][Full Text] [Related]
24. Chemistry and biology of roseophilin and the prodigiosin alkaloids: a survey of the last 2500 years.
Fürstner A
Angew Chem Int Ed Engl; 2003 Aug; 42(31):3582-603. PubMed ID: 12916029
[TBL] [Abstract][Full Text] [Related]
25. Prodigiosin 25-C uncouples vacuolar type H(+)-ATPase, inhibits vacuolar acidification and affects glycoprotein processing.
Kataoka T; Muroi M; Ohkuma S; Waritani T; Magae J; Takatsuki A; Kondo S; Yamasaki M; Nagai K
FEBS Lett; 1995 Feb; 359(1):53-9. PubMed ID: 7851530
[TBL] [Abstract][Full Text] [Related]
26. A prodigiosin from the roseophilin producer Streptomyces griseoviridis.
Kawasaki T; Sakurai F; Hayakawa Y
J Nat Prod; 2008 Jul; 71(7):1265-7. PubMed ID: 18553921
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the anti-Trichophyton activity of a prodigiosin analogue produced by gamma-proteobacterium, using stratum corneum epidermis of the Yucatan micropig.
Nakashima T; Kato Y; Yamaguchi K; Oda T
J Infect Chemother; 2005 Jun; 11(3):123-8. PubMed ID: 15990975
[TBL] [Abstract][Full Text] [Related]
28. Divalent transition-metal-ion stress induces prodigiosin biosynthesis in Streptomyces coelicolor M145: formation of coeligiosins.
Morgenstern A; Paetz C; Behrend A; Spiteller D
Chemistry; 2015 Apr; 21(16):6027-32. PubMed ID: 25760402
[TBL] [Abstract][Full Text] [Related]
29. Survivin modulation in the antimelanoma activity of prodiginines.
Branco PC; Pontes CA; Rezende-Teixeira P; Amengual-Rigo P; Alves-Fernandes DK; Maria-Engler SS; da Silva AB; Pessoa ODL; Jimenez PC; Mollasalehi N; Chapman E; Guallar V; Machado-Neto JA; Costa-Lotufo LV
Eur J Pharmacol; 2020 Dec; 888():173465. PubMed ID: 32814079
[TBL] [Abstract][Full Text] [Related]
30. Anion transporters and biological systems.
Gale PA; Pérez-Tomás R; Quesada R
Acc Chem Res; 2013 Dec; 46(12):2801-13. PubMed ID: 23551251
[TBL] [Abstract][Full Text] [Related]
31. Identification of a red-pigmented bacterium producing a potent anti-tumor N-alkylated prodigiosin as Serratia marcescens.
Deorukhkar AA; Chander R; Ghosh SB; Sainis KB
Res Microbiol; 2007 Jun; 158(5):399-404. PubMed ID: 17467243
[TBL] [Abstract][Full Text] [Related]
32. Biological Potential and Mechanism of Prodigiosin from
Li D; Liu J; Wang X; Kong D; Du W; Li H; Hse CY; Shupe T; Zhou D; Zhao K
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400387
[TBL] [Abstract][Full Text] [Related]
33. The production and bioactivity of prodigiosin: quo vadis?
Lin SR; Chen YH; Tseng FJ; Weng CF
Drug Discov Today; 2020 May; 25(5):828-836. PubMed ID: 32251776
[TBL] [Abstract][Full Text] [Related]
34. Total Synthesis and Biological Evaluation of Hybrubin A.
Jeffries DE; Lindsley CW
J Org Chem; 2017 Jan; 82(1):431-437. PubMed ID: 27966952
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic prodigiosin family pigments from Pseudoalteromonas sp. 1020R isolated from the Pacific coast of Japan.
Wang Y; Nakajima A; Hosokawa K; Soliev AB; Osaka I; Arakawa R; Enomoto K
Biosci Biotechnol Biochem; 2012; 76(6):1229-32. PubMed ID: 22790952
[TBL] [Abstract][Full Text] [Related]
36. Effects of prodigiosin 25-C on cultured cell lines: its similarity to monovalent polyether ionophores and vacuolar type H(+)-ATPase inhibitors.
Kataoka T; Magae J; Kasamo K; Yamanishi H; Endo A; Yamasaki M; Nagai K
J Antibiot (Tokyo); 1992 Oct; 45(10):1618-25. PubMed ID: 1473989
[TBL] [Abstract][Full Text] [Related]
37. Prodigiosin 25-C and metacycloprodigiosin suppress the bone resorption by osteoclasts.
Woo JT; Ohba Y; Tagami K; Sumitani K; Kataoka T; Nagai K
Biosci Biotechnol Biochem; 1997 Feb; 61(2):400-2. PubMed ID: 9058987
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic proteins combined with prodigiosin obtained from Serratia marcescens have both broad and selective cytotoxic activity on tumor cells.
Abrahantes-Pérez MC; Reyes-González J; Véliz Ríos G; Bequet-Romero M; Gómez Riera R; Anais Gasmury C; Huerta V; González LJ; Canino C; Garcia J; Váldez J; Reyes B; Váldes R; Martínez E
J Chemother; 2006 Apr; 18(2):172-81. PubMed ID: 16736886
[TBL] [Abstract][Full Text] [Related]
39. Recent advancements in high-level synthesis of the promising clinical drug, prodigiosin.
Yip CH; Yarkoni O; Ajioka J; Wan KL; Nathan S
Appl Microbiol Biotechnol; 2019 Feb; 103(4):1667-1680. PubMed ID: 30637495
[TBL] [Abstract][Full Text] [Related]
40. The biosynthesis and regulation of bacterial prodiginines.
Williamson NR; Fineran PC; Leeper FJ; Salmond GP
Nat Rev Microbiol; 2006 Dec; 4(12):887-99. PubMed ID: 17109029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
